Phase 2 Japanese Encephalitis Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
Japanese Encephalitis Virus Disease
SK Bioscience Co., Ltd.402 enrolled3 locationsNCT06680128
Recruiting
Phase 2
Understanding immune responses to the Yellow Fever (YF) and Japanese Encephalitis (JE) flavivirus vaccines (The FLAVIFLAV Study)
Japanese EncephalitisYellow Fever
The University of Melbourne88 enrolled1 locationACTRN12625000742471